Doctors of Tata Institute discovered a new cure for cancer, cancer will not occur for the second time Tata Institute New Cancer Treatment: To neutralize the chromogen, doctors gave pro-oxidant tablets of resveratrol and copper to the rats.

 Tata Institute New Cancer Treatment: Doctors and researchers of Tata Institute, Mumbai have achieved great success in the treatment of cancer. Doctors have developed a treatment that will help prevent the recurrence of serious diseases like cancer. Cancer is a serious and deadly disease and its treatment is also very difficult. In such a situation, this treatment discovered by the doctors of Tata Hospital has made the treatment of deadly diseases like cancer easier. This treatment has been discovered under the direction of Dr. Indranil Mitra of Tata Hospital's Advanced Center for Treatment, Research and Education in Cancer (ACTRAC) in Kharghar.

Testing done on rats

Once a cancer patient is cured, this treatment has been properly tested to reduce the risk of recurrence of cancer. Doctors gave a joint pro-oxidant tablet of resveratrol and copper to the rats. This tablet was effective in neutralizing chromozone. Tata doctors have been researching on this for almost a decade. This tablet is awaiting approval from the Food Safety and Standards Authority of India. Additionally, this treatment also incorporates advanced immunotherapy technology, which harnesses the power of the patient's immune system to help identify and destroy the cancer.

Speaking to a media organisation, Dr Rajendra of the hospital said, "For research, human cancer cells were inserted into mice, due to which a tumor formed in them. Then the mice were treated with radiation therapy, chemotherapy and surgery. It was found that that when these cancer cells die, they break up into smaller pieces, called chromatin particles. These particles can travel to other parts of the body through the bloodstream and when they enter healthy cells If they are, they can turn them into cancer." To correct this condition, the rats were given resveratrol and copper (R+Cu) pro-oxidant tablets. After consuming these pills, the effect of chromatin particles on their body gets destroyed, which reduces the risk of getting cancer again.

The tablet will hit the market by June-July

Researchers have said that this new drug R+Cu will be available in the market in June-July after getting the approval of the Food Safety and Standards Authority of India (FSSAI). It is claimed to be 30 percent effective in preventing the recurrence of a deadly disease like cancer and is 50 percent effective in protecting the patient's body from toxicity after cancer treatment.